Neuberger Berman Group’s Integra LifeSciences IART Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.5M | Sell |
858,566
-78,696
| -8% | -$966K | 0.01% | 784 |
|
2025
Q1 | $20.6M | Buy |
937,262
+17,812
| +2% | +$392K | 0.02% | 619 |
|
2024
Q4 | $20.8M | Buy |
919,450
+43,870
| +5% | +$995K | 0.02% | 643 |
|
2024
Q3 | $15.9M | Buy |
875,580
+47,031
| +6% | +$854K | 0.01% | 705 |
|
2024
Q2 | $24.1M | Buy |
828,549
+183,977
| +29% | +$5.36M | 0.02% | 594 |
|
2024
Q1 | $22.8M | Buy |
644,572
+144,143
| +29% | +$5.11M | 0.02% | 616 |
|
2023
Q4 | $21.8M | Buy |
500,429
+55,610
| +13% | +$2.42M | 0.02% | 601 |
|
2023
Q3 | $17M | Buy |
444,819
+285,686
| +180% | +$10.9M | 0.02% | 628 |
|
2023
Q2 | $6.55M | Buy |
159,133
+155,087
| +3,833% | +$6.38M | 0.01% | 831 |
|
2023
Q1 | $232K | Buy |
4,046
+267
| +7% | +$15.3K | ﹤0.01% | 1672 |
|
2022
Q4 | $212K | Buy |
+3,779
| New | +$212K | ﹤0.01% | 1675 |
|
2020
Q2 | – | Sell |
-12,500
| Closed | -$558K | – | 1556 |
|
2020
Q1 | $558K | Buy |
+12,500
| New | +$558K | ﹤0.01% | 1217 |
|
2017
Q1 | – | Sell |
-228,844
| Closed | -$19.6M | – | 1598 |
|
2016
Q4 | $19.6M | Sell |
228,844
-1,730
| -0.8% | -$148K | 0.03% | 590 |
|
2016
Q3 | $19M | Buy |
230,574
+24,343
| +12% | +$2.01M | 0.03% | 606 |
|
2016
Q2 | $16.5M | Sell |
206,231
-3,863
| -2% | -$308K | 0.02% | 644 |
|
2016
Q1 | $14.2M | Buy |
210,094
+76,574
| +57% | +$5.16M | 0.02% | 680 |
|
2015
Q4 | $9.05M | Buy |
+133,520
| New | +$9.05M | 0.01% | 787 |
|